Europe

Antibody levels fell to low or near zero within the first few months of getting the vaccine, unless the person had previously received a smallpox vaccine, scientists reported Saturday at the European Congress of Clinical Microbiology and Infectious Diseases in Barcelona.

Country / Region Tags:

Africa

Europe

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Situation Report

Read more about Mpox vaccine boosters necessary to restore faded protection -- Swedish study
Log in or register to post comments

Severity of infection and high blood presure lnked to long Covid--Swedish study

Thu, 2024-03-28 10:16 — mike kraft

Swedish study suggests link between long COVID and severity of illness Of those who had long COVID, 61% had been hospitalized after contracting the virus. CIDRAP

... high blood pressure may be a risk factor for developing the chronic condition. The study is published in BMJ Public Health.

...

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Situation Report

Read more about Severity of infection and high blood presure lnked to long Covid--Swedish study
Log in or register to post comments

Long COVID: More on research efforts

Wed, 2024-03-13 17:23 — mike kraft

What we know about long COVID — from brain fog to physical fatigue : Short Wave "Long COVID has affected every part of my life," said Virginia resident Rachel Beale said at a recent Senate hearing. "I wake up every day feeling tired, nauseous and dizzy. I immediately start planning when I can lay down again." Beale is far from alone. Many of her experiences have been echoed by others dealing with long COVID. It's a constellation of debilitating symptoms that range from brain fog and intense physical fatigue to depression and anxiety. But there's new, promising research that sheds light onto some symptoms. NPR health correspondent Will Stone talks with Short Wave host Regina G.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Situation Report

Read more about Long COVID: More on research efforts
Log in or register to post comments

Covid vaccines cut risk of virus-related heart failure and blood clots--international study

Wed, 2024-03-13 12:16 — mike kraft

Covid vaccines cut risk of virus-related heart failure and blood clots, study finds Researchers say jabs substantially reduce for up to a year the chances of serious cardiovascular complications The Guardian

...

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Read more about Covid vaccines cut risk of virus-related heart failure and blood clots--international study
Log in or register to post comments

EU needs trillions of investment for 2050 climate target - Green research

Tue, 2024-01-30 10:07 — mike kraft

EU needs trillions of investment for 2050 climate target - research The European Union will need 1.5 trillion euros ($1.6 trillion)per year of investments to meet its 2050 net zero emissions target, research backed by Green EU lawmakers said on Monday. Kate Abnett Reuters

...

Country / Region Tags:

General Topic Tags:

Sustainable Development

Problem, Solution, SitRep, or ?:

Analysis

Situation Report

Read more about EU needs trillions of investment for 2050 climate target - Green research
Log in or register to post comments

Information on Measles After WHO Sounds Alarm Over the Spreading Virus in Europe

Thu, 2024-01-25 12:34 — mike kraft

What You Need To Know About Measles After WHO Sounds Alarm Over Killer Virus In Europe There was a 45 fold increase in measles infections in Europe last year, the WHO said. Robert Hart Forbes

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Problem

Situation Report

Read more about Information on Measles After WHO Sounds Alarm Over the Spreading Virus in Europe
Log in or register to post comments

Emergency listing for Corbevax COVID vaccine approved by WHO

Tue, 2024-01-23 19:52 — mike kraft

WHO grants emergency listing for Corbevax COVID vaccine Non-exclusive licensing of the yeast strain by developers will allow others to develop effective, low-cost vaccines. CIDRAP

The World Health Organization (WHO) has approved another COVID-19 vaccine for emergency use listing (EUL): Corbevax, a recombinant protein–based vaccine developed by scientists at Texas Children's Hospital and Baylor College of Medicine.

Country / Region Tags:

General Topic Tags: